Publications by authors named "Shaun Zheng Sun"
JCO Oncol Pract
December 2024
Article Synopsis
- Canadian oncology patients often use patient assistance programs (PAPs) to access oncology drugs while waiting for funding, even within a universal healthcare system.
- A study reviewed the outcomes of 1,025 patients who received 40 oncology drugs, finding significant survival benefits with a median life-years gained calculated at 0.38 years for overall survival and 0.80 years for progression-free survival.
- The economic analysis revealed a total estimated value of quality-adjusted life years (QALY) gained of over $83 million, while the drug costs were about $97 million, highlighting the crucial role of PAPs in patient care and cost coverage.
